Hypertension Diagnostics (Hypertension Diagnostics) EV-to-FCF : (As of Jun. 03, 2024)

Hypertension Diagnostics EV-to-FCF Chart

Hypertension Diagnostics Annual Data
	Trend	Jun06	Jun07	Jun08	Jun09	Jun10	Jun11	Jun12	Dec16	Dec17	Dec18
EV-to-FCF		Get a 7-Day Free Trial					-17.49	-0.86	-	-	-

Hypertension Diagnostics Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19
EV-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Hypertension Diagnostics's EV-to-FCF

For the Shell Companies subindustry, Hypertension Diagnostics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypertension Diagnostics's EV-to-FCF Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Hypertension Diagnostics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Hypertension Diagnostics's EV-to-FCF falls into.

Hypertension Diagnostics EV-to-FCF Calculation

Hypertension Diagnostics's EV-to-FCF for today is calculated as:

Hypertension Diagnostics's current Enterprise Value is $0.03 Mil.
Hypertension Diagnostics's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics  (OTCPK:HDII) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hypertension Diagnostics's PE Ratio for today is calculated as:

Hypertension Diagnostics's share price for today is $0.0001.
Hypertension Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Hypertension Diagnostics EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Hypertension Diagnostics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Hypertension Diagnostics (Hypertension Diagnostics) Business Description